Research progresses on the regulatory roles of microRNAs in radiation-induced pulmonary fibrosis

Area of Science:

• Pulmonary Medicine
• Oncology
• Genetics

Background:

• Radiation-induced pulmonary fibrosis (RIPF) is a severe late-stage complication of radiation therapy.
• Current treatments for RIPF are limited, and its pathogenesis is not fully understood.
• Epigenetic modifications, especially microRNAs (miRNAs), are increasingly recognized as critical regulators in RIPF.

Purpose of the Study:

• To summarize the regulatory mechanisms of miRNAs in the development and progression of RIPF.
• To highlight the clinical potential of miRNAs as therapeutic targets for RIPF.
• To identify current research challenges in miRNA-based RIPF research.

Main Methods:

• Literature review of studies investigating miRNA roles in radiation-induced pulmonary fibrosis.
• Analysis of molecular mechanisms underlying miRNA regulation in RIPF pathogenesis.
• Evaluation of existing and potential therapeutic strategies targeting miRNAs for RIPF.

Main Results:

• miRNAs are implicated in key RIPF processes, including epithelial-mesenchymal transition (EMT), fibroblast activation, and extracellular matrix (ECM) deposition.
• Specific miRNAs have been identified as potential biomarkers and therapeutic targets for RIPF.
• The precise roles and interactions of miRNAs in RIPF pathogenesis require further elucidation.

Conclusions:

• miRNAs represent a promising avenue for developing novel therapeutic interventions for RIPF.
• Further research is needed to overcome challenges in translating miRNA-based strategies into clinical practice for radiation-induced lung injury.
• Understanding miRNA regulation is crucial for advancing RIPF treatment strategies.